Osteoporotic bone formation in mice lacking tob2; involvement of Tob2 in RANK ligand expression and osteoclasts differentiation (Q28505310)

GOA release 2020-03-11

author name string

Rieko Ajima

1

1 reference

24 January 2017

Toru Akiyama

2

1 reference

24 January 2017

Michihiko Usui

3

1 reference

24 January 2017

Mitsuhiro Yoneda

4

1 reference

24 January 2017

Yutaka Yoshida

5

1 reference

24 January 2017

Takahisa Nakamura

6

1 reference

24 January 2017

Osamu Minowa

7

1 reference

24 January 2017

Masaki Noda

8

1 reference

24 January 2017

Sakae Tanaka

9

1 reference

24 January 2017

Tetsuo Noda

10

1 reference

24 January 2017

Tadashi Yamamoto

Tob genes in development and homeostasis

11

1 reference

24 January 2017

language of work or name

English

0 references

publication date

16 April 2008

1 reference

24 January 2017

1 reference

24 January 2017

582

1 reference

24 January 2017

9

1 reference

24 January 2017

1313–1318

1 reference

24 January 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

Global control of gene expression in yeast by the Ccr4-Not complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

Oligo-astheno-teratozoospermia in mice lacking Cnot7, a regulator of retinoid X receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

Negative regulation of BMP/Smad signaling by Tob in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

Cloning and characterization of the mouse tob2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

Targeted mutation of the DNA methyltransferase gene results in embryonic lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

Cdc2-mediated phosphorylation of Kid controls its distribution to spindle and chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

Altered gene expression in the adult brain of fyn-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012

Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.03.012